Respiratory Care in Pulmonary Hypertension
Tracking # 20-915576
Course overview
Pulmonary hypertension (PH) is an uncommon disease that causes high blood pressure in the lungs of the affected individual. It is a progressive disease that can result in reduced life expectancy, along with reduced quality of life and reproductive limitations. Diagnosis and treatment of this disease are critical to improve life expectancy among sufferers and improve quality of life. It is important that clinicians understand how to recognize the signs of symptoms of different PH groups and how each is treated, how to determine the level of severity of a patients PH, and the clinicians role in assessing and managing patients with PH in both the inpatient and outpatient setting.
Subject areas
This course counts toward the state boards and subject areas below.
Alabama State Board of Respiratory Therapy
Licensed Respiratory Therapist
Arkansas State Medical Board - Respiratory Therapy
Respiratory Care Practitioner
Florida Board of Respiratory Care
Certified Respiratory Therapist
Registered Respiratory Therapist
Respiratory Care Practitioner Critical Care
Respiratory Care Practitioner Non-Critical Care
Georgia Composite Medical Board - Respiratory Care Professionals
Respiratory Care Professional
Kansas Board of Healing Arts - Respiratory Therapy
Respiratory Therapist
Louisiana State Board of Medical Examiners - Respiratory Therapy
Certified Respiratory Therapist
Licensed Respiratory Therapist
Registered Respiratory Therapist
MSDOH Bureau of Professional Licensure - Respiratory Care Practitioners
Respiratory Care Practitioner
New Hampshire Advisory Board of Respiratory Care Practitioners
Respiratory Care Practitioner
Oklahoma Board of Medical Licensure and Supervision - Respiratory Care
Respiratory Care Practitioner
Texas Medical Board - Respiratory Care Practitioners
Respiratory Care Practitioner
Disclosure statements
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.